Cargando…
Antibiotics and Therapeutic Agent Prescription in COVID-19 Management
Autores principales: | Zayet, Souheil, Klopfenstein, Timothée |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025734/ https://www.ncbi.nlm.nih.gov/pubmed/35453175 http://dx.doi.org/10.3390/antibiotics11040423 |
Ejemplares similares
-
Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022) -
A Comparative Systematic Review of COVID-19 and Influenza
por: Osman, Molka, et al.
Publicado: (2021) -
Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020
por: Zayet, Souheil, et al.
Publicado: (2020) -
Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
por: Zayet, Souheil, et al.
Publicado: (2022) -
Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France
por: Zayet, Souheil, et al.
Publicado: (2022)